The Center for Skeletal Research will further the discovery of the causes and therapies for skeletal diseases through the provision of core facilities and other programs designed to make the work of a broad group of investigators more efficient, interdisciplinary, innovative, and interactive. By making this research more effective, advances in understanding and therapy of osteoporosis and other bone disease will occur more quickly.
We provide high quality skeletally derived osteoblasts, osteoclasts, bone marrow stromal cells and osteocytes, as well as protocols and training for isolating, characterizing and isolating skeletally derived cells. We also develop novel techniques for isolating and studying bone cells.
The RNA seq core will provide help and advice with designing of bulk tissue and single cell RNA sequencing experiments, help with tissue and cell preparation, access to space and equipment, expertise for performing bulk RNA extractions from bone and cartilage tissue and computational and statistical interpretation of RNA sequencing data.
Provides/Enables Assays for Cell Signaling Pathways
cAMP, IP3, iCa, ERK-1/2, Multi-Array, 1,25 Dihydroxy Vitamin D, 25-Hydroxy Vitamin D, cAMP RIA, CTX-1,FGF-23, Fura-2 iCa++, Glosensor cAMP, IP1, P1NP, p-ERK-1/2, PTH.
Formats: Luminescence, RIA, ELISA, HTRF
Kit assays on a per-sample cost-basis.
Close interactions with the Imaging, Bone Cells and Signaling Cores will assure coordinated studies permitting imaging, histology, cell isolation, RNA and signaling analyses on skeletal elements from a single subject.
High-resolution micro-computed tomography (µCT) provides provides non-destructive, quantitative and qualitative assessment of trabecular and cortical bone microarchitecture.
Remember to acknowledge the Center for Skeletal Research if you received funding or services from our cores, see How to Cite P30.
P30 AR066261 – Core Services 2014 – May 31, 2019
P30 AR075042 – Core Services June 1, 2019 – May 31, 2024